Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis

被引:61
|
作者
Ren, J. [1 ]
Huan, Y. [1 ]
Wang, H. [2 ]
Chang, Y. -J. [1 ]
Zhao, H. -T. [1 ]
Ge, Ya. [1 ]
Liu, Y. [1 ]
Yang, Y. [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China
关键词
D O I
10.1016/j.crad.2007.07.023
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To investigate the diagnostic and differential diagnostic values of dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) in prostatic diseases, and to investigate the correlation between the parameters of SI-T curves and angiogenesis. MATERIALS AND METHODS: Twenty-one patients with proven prostatic carcinoma (Pca) and 29 patients with proven benign prostatic hyperptasia (BPH) were examined using DCE MRI. Diagnostic characteristics for differentiation were examined using threshold values for maximum peak time, enhancement degree, and enhancement rate. Then, the signal intensity-time curves (SI-T curves) were analysed, and the correlations between the parameters of SI-T curves and the expression Levels of vascular endothelial growth factor (VEGF) and microvascular density (MVD) were investigated. All patents underwent prostatectomy. DCE MRI and histological findings were correlated. RESULTS: Pca showed stronger enhancement with an earlier peak time, higher enhancement, and enhancement rate (p < 0.05). Regarding the type of SI-T curves, in the BPH group six were type A, 10 were type B, and 13 were type C, whereas in the Pca group, 14 were type A, six were type B, and only one was type C (Chi-square test, chi(2) = 13.57, P < 0.005). The VEGF and MVD expression levels of Pca were higher than those of BPH. Peak time was negativety correlated with the expression Levels of VEGF and MVD, whereas the enhancement degree and enhancement rate showed positive correlations (Pearson correlation, p < 0.05). CONCLUSION: Based on T2-weighted imaging, DCE MRI curves can help to differentiate benign from malignant prostate tissue. In the present study the type C curve was rarely seen with malignant disease, but these results need confirmation. (C) 2007 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 50 条
  • [1] Dynamic contrast-enhanced MRI of the prostate: Is this the way to proceed for characterization of prostatic carcinoma?
    Oyen, RH
    EUROPEAN RADIOLOGY, 2003, 13 (05) : 921 - 924
  • [2] Dynamic contrast-enhanced MRI of the prostate: Is this the way to proceed for characterization of prostatic carcinoma?
    R. H. Oyen
    European Radiology, 2003, 13 : 921 - 924
  • [3] The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia
    Moschouris, Hippocrates
    Stamatiou, Konstantinos
    Malagari, Katerina
    Marmaridou, Kyriaki
    Kladis-Kalentzis, Konstantinos
    Kiltenis, Michail
    Papadogeorgopoulos, Nikolaos
    Tsavari, Aikaterini
    Manoloudaki, Kassiani
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2019, 25 (02) : 134 - 143
  • [4] Evaluation of angiogenesis in benign prostatic hyperplasia and prostatic carcinoma, with correlations to Gleason Score
    Vrancianu, A.
    Vilaia, A.
    Tutuianu, L.
    Costache, D.
    Cioplea, M. D.
    Sticlaru, L.
    Mitroi, V.
    Nichita, L.
    VIRCHOWS ARCHIV, 2019, 475 : S187 - S188
  • [5] Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI
    Jia, Guang
    Heverhagen, Johannes T.
    Henry, Hannes
    Polzer, Hans
    Baudendistel, Klaus T.
    von Tengg-Kobligk, Hendrik
    Levine, Andrea L.
    Rosol, Thomas J.
    Knopp, Michael V.
    MAGNETIC RESONANCE IMAGING, 2006, 24 (06) : 721 - 725
  • [6] Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology
    Turnbull, LW
    Buckley, DL
    Turnbull, LS
    Liney, GP
    Knowles, AJ
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1999, 9 (02): : 311 - 316
  • [7] PROSTATIC-CARCINOMA AND BENIGN PROSTATIC HYPERPLASIA - MR IMAGING WITH HISTOPATHOLOGIC CORRELATION
    KAHN, T
    BURRIG, K
    SCHMITZDRAGER, B
    LEWIN, JS
    FURST, G
    MODDER, U
    RADIOLOGY, 1989, 173 (03) : 847 - 851
  • [8] Angiogenesis, inflammation and benign prostatic hyperplasia
    Baker, ME
    6TH CONGRESS OF THE MEDITERRANEAN UROLOGICAL ASSOCIATION, 1999, : 19 - 26
  • [9] The treatment of benign prostatic hyperplasia - In relation to prostatic carcinoma
    Greene, LF
    Thompson, GJ
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1943, 122 : 790 - 793
  • [10] PROSTATIC HEXOSAMINIDASE ACTIVITY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC-CARCINOMA
    WHITEHURST, GB
    MASHBURN, JP
    PRETLOW, TG
    BRADLEY, EL
    BOOHAKER, EA
    CANCER RESEARCH, 1982, 42 (10) : 4300 - 4303